A recent study indicates that people who stop using new GLP-1 drugs like Mounjaro or Wegovy tend to recover shed pounds far faster than those who stop traditional diet and exercise regimens.
Research printed in a leading medical journal points out that while overweight individuals frequently drop about a fifth of their body weight while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month once they quit.
"Users buying such medications need to be aware of the risk of fast weight regain when the therapy is stopped," warns researcher Dr. Susan Jebb.
Such speed of recovery implies a reversion to pre-treatment mass within about a year and a half.
Comparing Treatments
The research, which looked at dozens of studies involving over 9,000 of patients, contrasted the results of GLP-1 agonists with older methods.
Researchers emphasize that people who lose weight through diet and exercise typically experience a more gradual creep back—around 100 grams monthly—post-intervention.
Explaining the Fast Rebound
Doctors believe the way of the injections accounts for the accelerated weight return.
These medications copy a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Long-term administration of the hormone levels far above than the body's typical production could lead to the system to generate a reduced amount of its own natural GLP-1, and may also lessen responsiveness to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' results in hunger is uncontrolled, making excessive eating a significant risk."
A Lifelong Disease?
The NHS recommend the jabs for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.
Professionals contend that, due to the likelihood of weight regain, the therapy might need to be life-long.
This opinion is supported by pharmaceutical companies, who state that the results "underscore the persistent character of obesity," comparing it to managing diseases like hypertension.
User Accounts
Users who have come off the jabs describe a powerful return of hunger.
"It was like a switch that goes on and you're instantly starving," recalled an individual.
This difficulty is exacerbated if patients have not adopted permanent dietary or behavioural modifications during therapy.
Significant Interest
Figures indicate that a significant number of adults in the UK have used weight-loss jabs in the past year, with interest remaining high.
- Adoption is more common among women compared to men.
- The 40s and 50s demographic shows the greatest usage rates.
- Many access the drugs through private prescriptions rather than public health services.
In conclusion, experts caution that while the jabs are potent agents for weight loss, they are not a permanent solution and lasting health benefits hinges on ongoing lifestyle management.
